If you have been NEWLY DIAGNOSED START HERE
(SPANISH) ¿Cómo ha afectado el COVID-19 el diagnóstico de cáncer y qué puede hacer usted al respecto? Es hora de recordar la importancia de la...
From the Targeted Therapies Patient Forum 2019, Dr. Joshua Bauml and Dr. Joshua Sabari discuss RET, MET and BRAF, the initial treatment and acquired...
In this video series, presented in April of 2020, GRACE Faculty and Members of the Board of Directors have a candid discussion regarding cancer and...
In this video series, presented in April of 2020, GRACE Faculty and Members of the Board of Directors have a candid discussion regarding cancer and...
In this video series, presented in April of 2020, GRACE Faculty and Members of the Board of Directors have a candid discussion regarding cancer and...
Challenges and Issues the LGBTQ Community Face with CancerThe LGBTQ community celebrated Pride month in June, and, despite the ongoing pandemic, Pride...
GRACE has partnered with Lilly Oncology for the REThink Testing Campaign for Lung Cancer Awareness Month BRIDGING The Biomarker Gaps More than 1.8...
GRACE is pleased to announce the acceptance of three amazing individuals into the inaugural year of the GRACE Clinical Trials Experiences through...
GRACE is pleased to announce the acceptance of three amazing individuals into the inaugural year of the GRACE Clinical Trials Experiences through...
GRACE is pleased to announce the acceptance of three amazing individuals into the inaugural year of the GRACE Clinical Trials Experiences through...
I need information on adrenal metastasis from multifocal nsclc. Initial dx march 2019 surgical lobectomy complications eventually had to undergo...
When there is evidence of successful therapy of EGFR with TKI in one area of the lung but suggestion of progression in another area, what is the next...
The happiest of Thanksgiving to everyone! Thank you for being a part of GRACE!
From the Targeted Therapies Patient Forum 2019, Dr. Joshua Bauml and Dr. Joshua Sabari discuss RET, MET and BRAF, the initial treatment and acquired resistance.
To join the conversation, visit https://cancergrace.org/forum.
GRACE is excited to have again partnered with Clinical Care Options to develop an Interactive Decision Support Tool and downloadable resource to help you understand more about your disease and treatment options, so you can become partners with your oncology team in your cancer care.
The ADAURA clinic trial has proven that patients taking Tagrisso with IB-IIIA NSCLC had a 79% reduction in disease recurrence and the disease free survival rates were 89%. Based on this trial I of course want to get on this medication ASAP. Unfortunately, it hasn't been FDA approved for my group (Stage IIIA) yet and therefore my insurnce will not pay for it. Does anyone have any idea how I can obtain this medicine at a somewhat affordabel cost? Will Beacon Pharma sell Tagrix to me since I live in the US? Does Bonhoa have legitimate medication? All help is
My father have been on Tagrisso for 5 years since 2015 with no progression until recently. Below is the new CT report in July comparing the CT in Jan 2020.
He did have EGFR with T790M positive. Tagrisso is the second-line treatment with Iressa as the first-line. My father does not have any symptoms at the moment.
We live in Toronto with the possibility of clinical trials. Will be seeing our oncologist this Thursday.
Would love to get your thoughts on the following question:
1. Unfortunately, there are some signs of progression with the two bone mets.
Copyright © 2021 Global Resource for Advancing Cancer Education
Site by Freelock